A SPECIAL THANK YOU TO EVERYONE IN SUPPORT OF THE 2024 INNOVATION GALa
Powering the transformation of cancer research
The power of scientific intuition
Meet the people making the breakthroughs
Samir Parekh, MD
Professor of Medicine
Director of Translation Research in Myeloma
Icahn School of Medicine at Mt. Sinai, Division of Hematology/Medical Oncology
Non-Hodgkin’s lymphoma is the most common blood cancer worldwide. Mantel Cell Lymphoma (MCL) represents about 6 percent of all non-Hodgkin’s lymphoma.
Sandra Demaria, MD
Professor of Pathology and Laboratory Medicine, Pathology and Laboratory Medicine
Professor of Radiation Oncology, Radiation Oncology
Weill Cornell Medical College
In the last decade, there has been huge progress in clinical oncology. New therapies can help our natural self-defense system, the immune system, fight cancer successfully.
The Inspire NYC Award
Featuring our humanities honoree, Kevin Boseman
Writer, actor, and dancer Kevin Boseman, a cancer survivor, performs “The Butterfly” in tribute to his brother Chadwick and others struggling with cancer.
November 17, 2021
Solving the puzzle of cancer
Backing innovation for over 50 years
Gliomas can occur in the brain and in various locations in the nervous system, including the brain stem and spinal column. Some tumors, after several months, become treatment resistant. TCF researchers are looking at the mechanisms behind this resistance.
Our researchers are exploring different avenues to potentially more effective breast cancer treatments through hormone identification, radiation and immunotherapies, and the isolation of gene markers.
The relationship between irritable bowel disease and cancer has complicated treatment for patients. Our researchers are clarifying the approach.
Blood cancers can be very resistant to treatment. Our researchers are tackling some of the basic science behind some of the genetic markers in order to find better treatments.
Our researchers are finding breakthroughs in the treatment of these lymphatic system cancers that show promise for solid tumors as well.
We are backing basic research into the complex interactions and molecular pathways behind leukemia in both adults and children.
Exploring how the immune system does and doesn’t respond when there are genetic variations can help identify effective treatments in the future.
The power of the scientific community
Events and webinars
To be the catalyst that sparks a cure for cancer
Partnering institutions
Our Board of Trustees, Medical Directors, and Grantees are affiliated with leading research institutions in New York, New Jersey and Connecticut.
